|
AU509682B2
(en)
|
1975-10-28 |
1980-05-22 |
Eli Lilly And Company |
2-Aroyl-3-Phenylbenzothiophene Derivatives
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
EP0146243A1
(en)
|
1983-10-31 |
1985-06-26 |
Merck Frosst Canada Inc. |
Lipoxygenase inhibitors
|
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
|
EP0752421B1
(en)
|
1995-07-07 |
2005-10-12 |
AstraZeneca AB |
Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists
|
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
|
TW397821B
(en)
|
1996-04-19 |
2000-07-11 |
American Home Produits Corp |
3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
|
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
|
ATE263164T1
(de)
|
1997-10-03 |
2004-04-15 |
Lilly Co Eli |
Bentzothiophene
|
|
US6326392B1
(en)
|
1997-11-06 |
2001-12-04 |
American Home Products Corporation |
Anti-estrogen plus progestin containing oral contraceptives
|
|
ID24568A
(id)
|
1997-11-06 |
2000-07-27 |
American Home Prod |
Kontrasepsi oral yang mengandung anti-estrogen plus progestin
|
|
US6060488A
(en)
*
|
1998-09-22 |
2000-05-09 |
Eli Lilly And Company |
Benzothiophenes for treating estrogen deficiency
|
|
CO5271696A1
(es)
|
2000-01-12 |
2003-04-30 |
Pfizer Prod Inc |
Procedimiento para reducir la morbilidad y el riesgo de mortalidad
|
|
US7091240B2
(en)
|
2000-03-10 |
2006-08-15 |
Oxigene, Inc. |
Tubulin binding ligands and corresponding prodrug constructs
|
|
HK1052877A1
(zh)
|
2000-07-06 |
2003-10-03 |
Wyeth |
Ssri与雌激素剂之组合
|
|
US6358991B2
(en)
|
2000-07-06 |
2002-03-19 |
American Home Products Corporation |
Methods of treating neuropeptide Y-related conditions
|
|
AU2001271781A1
(en)
|
2000-07-06 |
2002-01-21 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
WO2002003990A2
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted insole compounds for treating excessive intraocular pressure
|
|
AU2001271784A1
(en)
|
2000-07-06 |
2002-01-21 |
Wyeth |
Therapy for prosthesis-related bone degeneration
|
|
AR030064A1
(es)
|
2000-07-06 |
2003-08-13 |
Wyeth Corp |
Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
|
|
AU2001273125A1
(en)
|
2000-07-06 |
2002-01-21 |
American Home Products Corporation |
Combinations of bisphosphonates, estrogenic agents and optionally estrogens
|
|
BR0112360A
(pt)
|
2000-07-06 |
2003-05-06 |
Wyeth Corp |
Método para aumentar a atividade da sintase de óxido nìtrico
|
|
WO2002003986A2
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating breast disorders
|
|
CA2414060A1
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Combinations of statins, estrogenic agents and optionally estrogens
|
|
PT1318837E
(pt)
|
2000-08-11 |
2004-12-31 |
Wyeth Corp |
Metodo de tratamenton de carcinoma positivo a receptor de estrogenio
|
|
EP1664052B1
(en)
|
2003-08-15 |
2009-02-18 |
AstraZeneca AB |
Fused heterocycles as inhibitors of glutamate racemase (muri)
|
|
FR2862646B1
(fr)
|
2003-11-20 |
2006-02-24 |
Merck Sante Sas |
Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
|
|
CA2595477A1
(en)
|
2005-01-21 |
2006-07-27 |
Janssen Pharmaceutica N.V. |
Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
|
|
EP1848704A4
(en)
|
2005-02-14 |
2011-05-11 |
Bionomics Ltd |
Novel tubulin polymerisation inhibitors
|
|
ES2386299T3
(es)
|
2006-02-03 |
2012-08-16 |
Bionomics Limited |
Benzofuranos, benzotiofenos, benzoselenofenos e indoles sustituidos y su uso como inhibidores de la polimerización de tubulina
|
|
CA2656067C
(en)
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
|
EP1947085A1
(en)
|
2007-01-19 |
2008-07-23 |
Laboratorios del Dr. Esteve S.A. |
Substituted indole sulfonamide compounds, their preparation and use as medicaments
|
|
AU2008280257A1
(en)
|
2007-07-25 |
2009-01-29 |
F. Hoffmann-La Roche Ag |
Benzofuran- and benzo[B]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
|
|
WO2010093578A1
(en)
|
2009-02-10 |
2010-08-19 |
Glaxo Group Limited |
Indolinyl-, benzofuranyl-, and benzothienyl- amides as modulators of chemokine receptors
|
|
EP2427430B1
(en)
|
2009-05-04 |
2014-09-10 |
The Royal Institution for the Advancement of Learning/McGill University |
5-oxo-ete receptor antagonist compounds
|
|
JP2013528223A
(ja)
|
2010-06-10 |
2013-07-08 |
アラゴン ファーマシューティカルズ，インク． |
エストロゲン受容体モジュレーターおよびその用途
|
|
GB2483736B
(en)
|
2010-09-16 |
2012-08-29 |
Aragon Pharmaceuticals Inc |
Estrogen receptor modulators and uses thereof
|
|
EP2655367B1
(en)
|
2010-12-24 |
2016-07-06 |
Merck Sharp & Dohme B.V. |
N-substituted azetidine derivatives
|
|
DE102011087987A1
(de)
|
2011-12-08 |
2013-06-13 |
Bayer Intellectual Property Gmbh |
6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
US9193714B2
(en)
|
2011-12-14 |
2015-11-24 |
Seragon Pharmaceuticals, Inc. |
Fluorinated estrogen receptor modulators and uses thereof
|
|
PE20150099A1
(es)
|
2011-12-16 |
2015-01-30 |
Olema Pharmaceuticals Inc |
Compuestos novedosos de benzopirano, composiciones y usos de los mismos
|
|
WO2013116293A1
(en)
|
2012-01-31 |
2013-08-08 |
Novartis Ag |
Combination of a rtk inhibitor with an anti - estrogen and use thereof for the treatment of cancer
|
|
NZ630124A
(en)
|
2012-03-20 |
2016-01-29 |
Seragon Pharmaceuticals Inc |
Estrogen receptor modulators and uses thereof
|
|
EP2911660B1
(en)
|
2012-10-24 |
2019-12-04 |
The Board of Trustees of the University of Illionis |
Compositions and methods for treating estrogen-related medical disorders
|
|
CA2928131C
(en)
|
2012-10-24 |
2023-02-07 |
The Board Of Trustees Of The University Of Illinois |
Benzothiophene derivatives and use thereof for treating estrogen-related medical disorders
|
|
MX359471B
(es)
*
|
2013-02-19 |
2018-09-28 |
Novartis Ag |
Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrogeno.
|
|
CA2899969A1
(en)
|
2013-03-14 |
2014-09-25 |
Seragon Pharmaceuticals, Inc. |
Polycyclic estrogen receptor modulators and uses thereof
|
|
LT3004090T
(lt)
|
2013-05-28 |
2018-01-10 |
Astrazeneca Ab |
Cheminiai junginiai
|
|
WO2014203132A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Substituted benzopyran compounds, compositions and uses thereof
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
JP6576916B2
(ja)
|
2013-06-19 |
2019-09-18 |
セラゴン ファーマシューティカルズ， インク． |
エストロゲン受容体モジュレーター及びその使用
|
|
CN105451735B
(zh)
|
2013-06-19 |
2019-01-11 |
西拉根制药公司 |
氮杂环丁烷雌激素受体调节剂和其用途
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
WO2015028409A1
(de)
|
2013-08-27 |
2015-03-05 |
Bayer Pharma Aktiengesellschaft |
6,7-dihydro-5h-benzo[7]annulen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
SG11201607334YA
(en)
|
2014-03-13 |
2016-10-28 |
Hoffmann La Roche |
Therapeutic combinations with estrogen receptor modulators
|
|
CA2941161A1
(en)
|
2014-03-13 |
2015-09-17 |
F.Hoffmann-La Roche Ag |
Methods and compositions for modulating estrogen receptor mutants
|
|
SMT202300072T1
(it)
|
2014-03-28 |
2023-05-12 |
Univ Duke |
Cancro della mammella mediante l'utilizzo di modulatori selettivi del recetiore degli estrogeni
|
|
US9845291B2
(en)
|
2014-12-18 |
2017-12-19 |
Genentech, Inc. |
Estrogen receptor modulators and uses thereof
|
|
WO2016097073A1
(en)
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Derivatives of 2,3-diphenylchromene useful for the treatment of cancer
|
|
CN107108611B
(zh)
|
2014-12-18 |
2020-09-25 |
豪夫迈·罗氏有限公司 |
四氢-吡啶并[3,4-b]吲哚雌激素受体调节剂及其用途
|
|
EP3303326B1
(en)
|
2015-05-26 |
2020-12-16 |
H. Hoffnabb-La Roche Ag |
Heterocyclic estrogen receptor modulators and uses thereof
|
|
DK3355884T3
(da)
|
2015-10-01 |
2021-08-02 |
Olema Pharmaceuticals Inc |
Tetrahydro-1h-pyrido[3,4-b]indol-antiøstrogenlægemidler
|
|
WO2017056115A1
(en)
|
2015-10-03 |
2017-04-06 |
Sun Pharma Advanced Research Company Limited |
Novel n-aryl containing fused heterocyclic compounds
|
|
US9975856B2
(en)
|
2015-10-07 |
2018-05-22 |
Genentech, Inc. |
Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
|
|
RS63217B1
(sr)
|
2015-10-27 |
2022-06-30 |
Sun Pharma Advanced Res Co Ltd |
Novi heterociklični antiestrogeni
|
|
WO2017100715A1
(en)
|
2015-12-09 |
2017-06-15 |
The Board Of Trustees Of The University Of Illinois |
Benzothiophene-based selective estrogen receptor downregulator compounds
|
|
HRP20211043T1
(hr)
|
2016-02-15 |
2021-10-01 |
Sanofi |
Derivati 6,7-dihidro-5h-benzo[7]anulena kao modulatori estrogenskih receptora
|